🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/08/2018 16,04 16,95 15,75 16,51 +2,42% 7,48% 1.234.200
08/08/2018 15,44 16,20 15,21 16,12 +6,75% 6,41% 1.846.500
07/08/2018 14,29 15,28 14,05 15,10 +6,04% 8,61% 2.156.200
06/08/2018 14,43 14,49 13,76 14,24 -2,06% 5,06% 1.288.100
03/08/2018 15,27 15,40 14,30 14,54 -5,09% 7,20% 1.005.500
02/08/2018 14,98 15,38 14,71 15,32 +1,19% 4,47% 865.700
01/08/2018 14,57 15,16 14,56 15,14 +3,91% 4,12% 1.341.000
31/07/2018 14,20 15,30 14,10 14,57 +4,07% 8,45% 2.390.600
30/07/2018 15,96 16,22 12,25 14,00 -12,88% 24,84% 7.041.200
27/07/2018 17,50 17,50 16,01 16,07 -7,86% 8,51% 1.502.600
26/07/2018 16,89 17,50 16,50 17,44 +3,26% 5,92% 1.673.700
25/07/2018 16,64 17,30 16,61 16,89 +1,75% 4,15% 1.450.300
24/07/2018 16,74 17,50 16,18 16,60 +0,55% 7,89% 2.142.100
23/07/2018 16,08 16,87 15,66 16,51 +2,99% 7,53% 1.490.500
20/07/2018 16,29 16,56 15,78 16,03 -1,72% 4,79% 1.409.800
19/07/2018 16,60 16,65 16,15 16,31 -2,16% 3,01% 1.475.000
18/07/2018 16,49 17,18 16,32 16,67 +1,34% 5,22% 2.256.000
17/07/2018 15,72 16,47 15,62 16,45 +4,11% 5,41% 1.085.900
16/07/2018 16,20 16,76 15,53 15,80 -3,72% 7,59% 1.516.000
13/07/2018 16,41 16,48 16,00 16,41 +0,00% 2,93% 838.900
12/07/2018 16,45 16,64 16,06 16,41 -0,06% 3,53% 1.663.100
11/07/2018 16,00 16,50 15,63 16,42 +1,92% 5,44% 1.417.400
10/07/2018 16,32 16,50 15,84 16,11 -1,77% 4,04% 1.555.300
09/07/2018 16,00 16,40 15,58 16,40 +3,60% 5,12% 1.889.800
06/07/2018 15,28 15,88 15,15 15,83 +3,46% 4,78% 1.845.800
05/07/2018 15,10 15,31 14,74 15,30 +1,86% 3,77% 1.704.300
03/07/2018 14,84 15,75 14,66 15,02 +1,01% 7,35% 1.492.200
02/07/2018 13,71 14,93 13,33 14,87 +9,34% 11,67% 2.713.000
29/06/2018 13,14 13,79 12,89 13,60 +5,02% 6,89% 2.284.600
28/06/2018 13,22 13,25 12,61 12,95 -2,04% 4,84% 1.823.400